Skip to content

Research at St Andrews

Longitudinal PKPD biomarkers correlate with treatment outcome in drug sensitive pulmonary tuberculosis; a population pharmacokinetic-pharmacodynamic analysis

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Frank Kloprogge, Henry C. Mwandumba, Mercy Kamdolozi, Gertrude Banda, Doris Shani, Elizabeth L. Corbett, Nadia Kontogianni, Steve Ward, Saye H. Khoo, Geraint R. Davies, Derek James Sloan

School/Research organisations

Abstract

Background. This study aims to explore relationships between baseline demographic covariates, plasma antibiotic exposure, sputum bacillary load, and clinical outcome data to help improve future tuberculosis (TB) treatment response predictions.

Methods. Data were available from a longitudinal cohort study in Malawian drug-sensitive TB patients on standard therapy, including steady-state plasma antibiotic exposure (154 patients), sputum bacillary load (102 patients), final outcome (95 patients), and clinical details. Population pharmacokinetic and pharmacokinetic-pharmacodynamic models were developed in the software package NONMEM. Outcome data were analyzed using univariate logistic regression and Cox proportional hazard models in R, a free software for statistical computing.

Results. Higher isoniazid exposure correlated with increased bacillary killing in sputum (P < .01). Bacillary killing in sputum remained fast, with later progression to biphasic decline, in patients with higher rifampicin area under the curve (AUC)0-24 (P < .01). Serial sputum colony counting negativity at month 2 (P < .05), isoniazid CMAX (P < .05), isoniazid CMAX/minimum inhibitory concentration ([MIC] P < .01), and isoniazid AUC0-24/MIC (P < .01) correlated with treatment success but not with remaining free of TB. Slower bacillary killing (P < .05) and earlier progression to biphasic bacillary decline (P < .01) both correlate with treatment failure. Posttreatment recurrence only correlated with slower bacillary killing (P < .05).

Conclusions. Patterns of early bacillary clearance matter. Static measurements such as month 2 sputum conversion and pharmacokinetic parameters such as CMAX/MIC and AUC0-24/MIC were predictive of treatment failure, but modeling of quantitative longitudinal data was required to assess the risk of recurrence. Pooled individual patient data analyses from larger datasets are needed to confirm these findings.
Close

Details

Original languageEnglish
Article numberofaa218
Number of pages11
JournalOpen Forum Infectious Diseases
Volume7
Issue number7
Early online date6 Jun 2020
DOIs
Publication statusPublished - Jul 2020

    Research areas

  • Outcome, Pharmacokinetics, Pharmacodynamics, Standard treatment, Tuberculosis

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. STrengthening the Reporting Of Pharmacogenetic Studies: development of the STROPS guideline

    Chaplin, M., Kirkham, J. J., Dwan, K., Sloan, D. J., Davies, G. & Jorgensen, A. L., 21 Sep 2020, In : PLoS Medicine. 17, 9, 11 p., e1003344.

    Research output: Contribution to journalArticle

  2. Utility of broad-spectrum antibiotics for diagnosing pulmonary tuberculosis in adults: a systematic review and meta-analysis

    Divala, T. H., Fielding, K. L., Kandulu, C., Nliwasa, M., Sloan, D. J., Gupta-Wright, A. & Corbett, E. L., 1 Sep 2020, In : Lancet Infectious Diseases. 20, 9, p. 1089-1098 10 p.

    Research output: Contribution to journalArticle

  3. Intrapulmonary pharmacokinetics of first-line anti-TB drugs in Malawian tuberculosis patients

    McCallum, A. D., Pertinez, H. E., Else, L. J., Dilly-Penchala, S., Chirambo, A. P., Sheha, I., Chasweka, M., Chitani, A., Malamba, R. D., Meghji, J. Z., Gordon, S. B., Davies, G. R., Khoo, S. H., Sloan, D. J. & Mwandumba, H. C., 28 Aug 2020, In : Clinical Infectious Diseases.

    Research output: Contribution to journalArticle

  4. Tuberculosis bacillary load, an early marker of disease severity and treatment response: the utility of tuberculosis Molecular Bacterial Load Assay

    Sabiiti, W., Azam, K., Farmer, E., Kuchaka, D., Mtafya, B., Bowness, R., Oravcova, K., Honeyborne, I., Evangelopoulos, D., McHugh, T. D., Khosa, C., Rachow, A., Heinrich, N., Kampira, E., Davies, G., Bhatt, N., Ntinginya, E. N., Viegas, S., Jani, I., Kamdolozi, M. & 8 others, Mdolo, A., Khonga, M., Boeree, M. J., Phillips, P. PJ., Sloan, D. J., Hoelscher, M., Kibiki, G. & Gillespie, S. H., Jul 2020, In : Thorax. 75, 7, p. 606-608 3 p.

    Research output: Contribution to journalArticle

  5. A tuberculosis molecular bacterial load assay (TB-MBLA)

    Sabiiti, W., Mtafya, B. A., Alferes De Lima, D., Dombay, E., Baron, V. O., Azam, K., Orascova, K., Sloan, D. J. & Gillespie, S. H., 30 Apr 2020, In : Journal of Visualized Experiments. 158, 10 p., e60460.

    Research output: Contribution to journalArticle

Related by journal

  1. Corrigendum to: Transfusion-transmitted malaria: a systematic review and meta-analysis (Open Forum Infectious Diseases (2019) 6:7 (ofz283) DOI: 10.1093/ofid/ofz283)

    Ahmadpour, E., Foroutan-Rad, M., Majidiani, H., Moghaddam, S. M., Hatam-Nahavandi, K., Hosseini, S-A., Rahimi, M. T., Barac, A., Rubino, S., Zarean, M., Mathioudakis, A. G. & Cevik, M., Jan 2020, In : Open Forum Infectious Diseases. 7, 1, 1 p., ofz540.

    Research output: Contribution to journalComment/debate

  2. Transfusion-transmitted malaria: a systematic review and meta-analysis

    Ahmadpour, E., Foroutan-Rad, M., Majidiani, H., Moghaddam, S. M., Hatam-Nahavandi, K., Hosseini, S-A., Rahimi, M. T., Barac, A., Rubino, S., Zarean, M., Mathioudakis, A. G. & Cevik, M., Jul 2019, In : Open Forum Infectious Diseases. 6, 7, 8 p., ofz283.

    Research output: Contribution to journalArticle

ID: 269485795

Top